Reevaluation of Positivity Cutoff Values for the Pneumococcal Urinary Antigen Detection Assay

Por Pride, Michael W., Jansen, Kathrin U.
Publicado no Clin Vaccine Immunol (2017)

Kinetics and isotype profile of antibody responses in rhesus macaques induced following vaccination with HPV 6, 11, 16 and 18 L1-virus-like particles formulated with or without Mer...

Por Ruiz, Wanda, McClements, William L, Jansen, Kathrin U, Esser, Mark T
Publicado em 2005

Covering all the Bases: Preclinical Development of an Effective Staphylococcus aureus Vaccine

Por Scully, Ingrid L., Liberator, Paul A., Jansen, Kathrin U., Anderson, Annaliesa S.
Publicado em 2014

Adult vaccination: Current recommendations and future prospects

Por Swanson, Kena A, Schmitt, H Josef, Jansen, Kathrin U, Anderson, Annaliesa S
Publicado no Hum Vaccin Immunother (2014)

Staphylococcus aureus Clumping Factor A Remains a Viable Vaccine Target for Prevention of S. aureus Infection

Por Anderson, Annaliesa S., Scully, Ingrid L., Buurman, Ed T., Eiden, Joseph, Jansen, Kathrin U.
Publicado no mBio (2016)

The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A

Por Cooper, David, Yu, Xinhong, Sidhu, Mohinder, Nahm, Moon H., Fernsten, Philip, Jansen, Kathrin U.
Publicado em 2011

Regulation of Staphylococcus aureus MntC Expression and Its Role in Response to Oxidative Stress

Por Handke, Luke D., Hawkins, Julio C., Miller, Alita A., Jansen, Kathrin U., Anderson, Annaliesa S.
Publicado em 2013

Development of a subunit vaccine for prevention of Clostridium difficile associated diseases: Biophysical characterization of toxoids A and B

Por Gribenko, Alexey, Severina, Elena, Sidhu, Maninder K., Jansen, Kathrin U., Green, Bruce A., Matsuka, Yury V.
Publicado no Biochem Biophys Rep (2017)

Infectious Virions Produced from a Human Papillomavirus Type 18/16 Genomic DNA Chimera

Por Meyers, Craig, Bromberg-White, Jennifer L., Zhang, Jiaping, Kaupas, Michelle E., Bryan, Janine T., Lowe, Robert S., Jansen, Kathrin U.
Publicado em 2002

Vaccination strategies for the prevention of meningococcal disease

Por Vuocolo, Scott, Balmer, Paul, Gruber, William C., Jansen, Kathrin U., Anderson, Annaliesa S., Perez, John L., York, Laura J.
Publicado no Hum Vaccin Immunother (2018)

Simultaneous Quantitation of Antibodies to Neutralizing Epitopes on Virus-Like Particles for Human Papillomavirus Types 6, 11, 16, and 18 by a Multiplexed Luminex Assay

Por Opalka, David, Lachman, Charles E., MacMullen, Stefani A., Jansen, Kathrin U., Smith, Judith F., Chirmule, Narendra, Esser, Mark T.
Publicado em 2003

Reproductive tract infections in rural women from the highlands, jungle, and coastal regions of Peru.

Por García, Patricia J., Chavez, Susana, Feringa, Barbara, Chiappe, Marina, Li, Weili, Jansen, Kathrin U., Cárcamo, César, Holmes, King K.
Publicado em 2004

Development of a multicomponent Staphylococcus aureus vaccine designed to counter multiple bacterial virulence factors

Por Anderson, Annaliesa S., Miller, Alita A., Donald, Robert G.K., Scully, Ingrid L., Nanra, Jasdeep S., Cooper, David, Jansen, Kathrin U.
Publicado em 2012

Potential impact of the bivalent rLP2086 vaccine on Neisseria meningitidis carriage and invasive serogroup B disease

Por Anderson, Annaliesa S., Hao, Li, Jiang, Qin, Harris, Shannon L., Jones, Thomas R., Perez, John L., York, Laura, Eiden, Joseph, Jansen, Kathrin U.
Publicado em 2013

Role of Factor H Binding Protein in Neisseria meningitidis Virulence and Its Potential as a Vaccine Candidate To Broadly Protect against Meningococcal Disease

Por McNeil, Lisa K., Zagursky, Robert J., Lin, Shuo L., Murphy, Ellen, Zlotnick, Gary W., Hoiseth, Susan K., Jansen, Kathrin U., Anderson, Annaliesa S.
Publicado em 2013

Priming of Human Papillomavirus Type 11-Specific Humoral and Cellular Immune Responses in College-Aged Women with a Virus-Like Particle Vaccine

Por Emeny, Rebecca T., Wheeler, Cosette M., Jansen, Kathrin U., Hunt, William C., Fu, Tong-Ming, Smith, Judith F., MacMullen, Stefani, Esser, Mark T., Paliard, Xavier
Publicado em 2002

Preclinical evidence for the potential of a bivalent fHBP vaccine to prevent Neisseria meningitidis serogroup C disease

Por Harris, Shannon L, Zhu, Duzhang, Murphy, Ellen, McNeil, Lisa K, Wang, Xin, Mayer, Leonard W, Harrison, Lee H, Jansen, Kathrin U, Anderson, Annaliesa S
Publicado em 2011

Optimization of Molecular Approaches to Genogroup Neisseria meningitidis Carriage Isolates and Implications for Monitoring the Impact of New Serogroup B Vaccines

Por Rojas, Eduardo, Hoyos, Johanna, Oldfield, Neil J., Lee, Philip, Flint, Mike, Jones, C. Hal, Ala’Aldeen, Dlawer A. A., Jansen, Kathrin U., Anderson, Annaliesa S.
Publicado no PLoS One (2015)

Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine formulations with and without aluminum phosphate and comparison of the formulation of choice with 23-valent pn...

Por Juergens, Christine, de Villiers, Pierre JT, Moodley, Keymanthri, Jayawardene, Deepthi, Jansen, Kathrin U, Scott, Daniel A, Emini, Emilio A, Gruber, William C, Schmoele-Thoma, Beate
Publicado no Hum Vaccin Immunother (2014)

Staphylococcus aureus Manganese Transport Protein C Is a Highly Conserved Cell Surface Protein That Elicits Protective Immunity Against S. aureus and Staphylococcus epidermidis

Por Anderson, Annaliesa S., Scully, Ingrid L., Timofeyeva, Yekaterina, Murphy, Ellen, McNeil, Lisa K., Mininni, Terri, Nuñez, Lorna, Carriere, Marjolaine, Singer, Christine, Dilts, Deborah A., Jansen, Kathrin U.
Publicado em 2012